Literature DB >> 3059897

Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure.

D E O'Donnell1, R Sanii, M Younes.   

Abstract

To cope with the increased ventilatory demands of exercise, patients with severe expiratory flow limitation adopt strategies that ultimately place greater demands on their inspiratory muscles. Increased inspiratory muscle work may contribute to dyspnea causation and exercise limitation in such patients even before their ventilatory ceiling is attained. In this setting, continuous positive airway pressure (CPAP) should, by favorably affecting inspiratory muscle function and respiratory sensation, improve exercise performance. Six patients with chronic airflow limitation (CAL) (FEV1 +/- SD = 35 +/- 12% predicted) undertook constant-load, submaximal, cycle exercise at 50% of their predetermined maximal oxygen consumption: CPAP of 4 to 5 cm H2O was delivered during one exercise session and bracketed by one or two unassisted control sessions. In four patients, CPAP-assisted (4 to 5 cm H2O) exercise was bracketed by two unassisted control exercise sessions; two remaining patients undertook CPAP-assisted exercise and one unassisted control session. CPAP resulted in a significant increase in exercise endurance time (TLIM) (by 48%: CPAP TLIM (mean +/- SE) = 8.82 +/- 1.90 min; averaged control TLIM = 5.98 +/- 1.23 min (p less than 0.01). CPAP effectively ameliorated exertional dyspnea in the majority of patients; selected dyspnea ratings (Borg scale) during control (final minute) and CPAP at isotime, at comparable levels of ventilation, were (mean +/- SD) 7.83 +/- 2.25 and 5.5 +/- 2.2, respectively (p less than 0.025). Breathing frequency fell significantly during CPAP application (at isotime) by 17% (p less than 0.02); other steady-state ventilatory variables and end-expiratory lung volumes were not significantly different during CPAP and control.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3059897     DOI: 10.1164/ajrccm/138.6.1510

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Use of continuous negative pressure around the chest increases exercise performance in chronic obstructive pulmonary disease patients: a pilot study.

Authors:  Rakesh K Chaturvedi; Arnold Zidulka
Journal:  Can Respir J       Date:  2011 Jan-Feb       Impact factor: 2.409

Review 2.  Exercise in patients with chronic obstructive pulmonary disease.

Authors:  M J Belman
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

3.  Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease.

Authors:  S E Keilty; J Ponte; T A Fleming; J Moxham
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

4.  Non invasive ventilation as an additional tool for exercise training.

Authors:  Nicolino Ambrosino; Paolo Cigni
Journal:  Multidiscip Respir Med       Date:  2015-04-09

Review 5.  Pathogenesis of hyperinflation in chronic obstructive pulmonary disease.

Authors:  Philippe Gagnon; Jordan A Guenette; Daniel Langer; Louis Laviolette; Vincent Mainguy; François Maltais; Fernanda Ribeiro; Didier Saey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-15

Review 6.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

7.  Effects of breathing maneuver and sitting posture on muscle activity in inspiratory accessory muscles in patients with chronic obstructive pulmonary disease.

Authors:  Ki-Song Kim; Min-Kwang Byun; Won-Hwee Lee; Heon-Seock Cynn; Oh-Yun Kwon; Chung-Hwi Yi
Journal:  Multidiscip Respir Med       Date:  2012-06-20

8.  The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial.

Authors:  Atsushi Suzuki; Masahiko Ando; Tomoki Kimura; Kensuke Kataoka; Toshiki Yokoyama; Eiichi Shiroshita; Yasuhiro Kondoh
Journal:  BMC Pulm Med       Date:  2020-02-24       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.